Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life

Pediatrics

Volumn 128, Issue 2, 2011, Pages

  Brunklaus, Andreas ^a,b,c   Pohl, Keith ^d   Zuberi, Sameer M ^a   De Sousa, Carlos ^c  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Dancing eye syndrome; DES; OMS; Opsoclonus myoclonus syndrome

Indexed keywords

AZATHIOPRINE; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISOLONE;

ABNORMAL BEHAVIOR; ADOLESCENT; ARTICLE; CHILD; COGNITIVE DEFECT; CONTROLLED STUDY; CUSHINGOID SYNDROME; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; GROWTH DISORDER; HIRSUTISM; HUMAN; HYPERTENSION; IMMUNOMODULATION; IMMUNOTHERAPY; INFANT; INTELLIGENCE QUOTIENT; LEARNING DISORDER; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; NEUROBLASTOMA; OPSOCLONUS MYOCLONUS SYNDROME; OUTCOMES RESEARCH; PATHOLOGIC FRACTURE; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SPEECH DISORDER; SYMPTOMATOLOGY; TREATMENT RESPONSE;

CHRONIC DISEASE; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; OPSOCLONUS-MYOCLONUS SYNDROME; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80051488929     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-3114     Document Type: Article

References (32)

1. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatr. 1962;25(3):271-276
2. Mitchell WG, Davalos-Gonzalez Y, Brumm VL, et al. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae [published correction appears in Pediatrics. 2002;110(4):853-854]. Pediatrics. 2002;109(1):86-98 (Pubitemid 34049431)
3. Connolly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol. 1994;35(6):673-679 (Pubitemid 24172166)
4. Tate ED, Allison TJ, Pranzatelli MR, Verhu SJ. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs. 2005;22(1):8-19 (Pubitemid 40091116)
5. Raffaghello L, Conte M, De Grandis E, Pistoia V. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma. Eur J Paediatr Neurol. 2009;13(3):219-223
6. Blaes F, Pike MG, Lang B. Autoantibodies in childhood opsoclonus-myoclonus syndrome. J Neuroimmunol. 2008;201-202:221-226
7. Connolly AM, Pestronk A, Mehta S, Pranzatelli MR, Noetzel MJ. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr. 1997;130(6):878-884 (Pubitemid 27495114)
8. Korfei M, Fühlhuber V, Schmidt T, Kaps M, Preissner KT, Blaes F. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome. J Neuroimmunol. 2005;170(1-2):150-157 (Pubitemid 41740916)
9. Altman AJ, Baehner RL. Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma. Cancer. 1976;37(2):846-852
10. Koh PS, Raffensperger JG, Berry S, et al. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr. 1994;125(5 pt 1):712-716 (Pubitemid 24350179)
11. Russo C, Cohn SL, Petruzzi MJ, de Alarcon PA. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol. 1997;28(4):284-288 (Pubitemid 27123691)
12. Biasotti S, Garaventa A, Villavecchia GP, Cabria M, Nantron M, Bernardi BD. Falsenegative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma. Med Pediatr Oncol. 2000;35(2):153-155
13. Pang K, de Sousa C, Lang B, Pike MG. A prospective study of the presentation and management of dancing eye syndrome/opsoclonus-myoclonus syndrome in the United Kingdom. Eur J Paediatr Neurol. 2010;14(2):156-161
14. Mitchell WG, Brumm VL, Azen CG, Patterson KE, Aller SK, Rodriguez J. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia. Pediatrics. 2005;116(4):901-907 (Pubitemid 44542816)
15. Klein A, Schmitt B, Boltshauser E. Long-term outcome of ten children with opsoclonus-myoclonus syndrome. Eur J Pediatr. 2007;166(4):359-363 (Pubitemid 46295094)
16. Krug P, Schleiermacher G, Michon J, et al. Opsoclonus-myoclonus in children associated or not with neuroblastoma. Eur J Paediatr Neurol. 2010;14(5):400-409
17. Pohl KRE, Pritchard J, Wilson J. Neurological sequelae of the dancing eye syndrome. Eur J Pediatr. 1996;155(3):237-244 (Pubitemid 26053363)
18. Pranzatelli MR, Tate ED, Travelstead AL, et al. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol. 2006;28(9):585-593 (Pubitemid 44496336)
19. Pranzatelli MR, Tate ED, Swan JA, et al. B cell depletion therapy for new-onset opsoclonus-myoclonus. Mov Disord. 2010;25(2):238-242
20. Matthay KK, Blaes F, Hero B, et al. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the Advances in Neuroblastoma meeting in Genoa, Italy, 2004. Cancer Lett. 2005;228(1-2):275-282 (Pubitemid 41188452)
21. De Grandis E, Parodi S, Conte M, et al. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics. 2009;40(3):103-111
22. Nishihira H, Toyoda Y, Tanaka Y, et al. Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution. J Clin Oncol. 2000;18(16):3012-3017 (Pubitemid 30644126)
23. Pranzatelli MR, Travelstead AL, Tate ED, et al. B- and T-cell markers in opsoclonusmyoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology. 2004;62(9):1526-1532 (Pubitemid 38608190)
24. Jacobs RK, Anderson VA, Neale JL, Shield LK, Kornberg AJ. Neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset. Pediatr Neurol. 2004;31(3):191-197 (Pubitemid 39221245)
25. Pentland LM, Anderson VA, Wrennall J. The implications of childhood bacterial meningitis for language development. Child Neuropsychol. 2000;6(2):87-100 (Pubitemid 32009698)
26. Smibert E, Anderson V, Godber T, Ekert H. Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia. Br J Cancer. 1996;73(6):825-830 (Pubitemid 26105314)
27. Anderson VA, Spencer-Smith M, Coleman L, et al. Children's executive functions: are they poorer after very early brain insult. Neuropsychologia. 2010;48(7):2041-2050
28. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 1997;387(2):167-178 (Pubitemid 27430343)
29. Bataller L, Graus F, Saiz A, Vilchez JJ. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124(pt 2):437-443 (Pubitemid 32142415)
30. Ertle F, Behnisch W, Al Mulla NA, et al. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses. Pediatr Blood Cancer. 2008;50(3):683-687 (Pubitemid 351155860)
31. Rostásy K, Wilken B, Baumann M, et al. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome. Neuropediatrics. 2006;37(5):291-295 (Pubitemid 46180809)
32. Pranzatelli MR, Tate ED, Kinsbourne M, Caviness VS Jr, Mishra B. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIg. Mov Disord. 2002;17(6):1387-1390 (Pubitemid 36041365)